WealthShield Partners’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
BFG
WealthShield Partners's FBT Position: Q2 2026 in Review
WealthShield Partners sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2026, closing a stake of 4,689 shares — an estimated $942K sold.
WealthShield Partners first reported a position in FBT in Q4 2017 and held it in 25 quarters. The position peaked at $995K in Q4 2025. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.
- WealthShield Partners reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2026 after selling out during the quarter.
- WealthShield Partners sold 4,689 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $942K.
- WealthShield Partners first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2017 and held it in 25 quarters.
- WealthShield Partners's First Trust NYSE Arca Biotechnology Index Fund position peaked at $995K in Q4 2025.
- 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.
Based on WealthShield Partners's 13F filing for Q2 2026, filed 12 Aug 2026.